Daclatasvir Dihydrochloride Tablets

Key Benefits
- Used as part of combination treatment for chronic hepatitis C
- Helps inhibit hepatitis C virus replication
- Targets the HCV NS5A protein
- Supports viral suppression during the prescribed treatment course
- May help achieve sustained virologic response when used with appropriate antiviral therapy
How It Works
Daclatasvir inhibits the HCV NS5A protein, which plays an essential role in viral RNA replication and the assembly of new hepatitis C virus particles. By interfering with this protein, daclatasvir helps prevent the virus from multiplying and supports clearance of HCV when used in an appropriate combination regimen.
Common Side Effects
- Headache
- Fatigue
- Nausea
- Diarrhea
- Dizziness
- Insomnia
- Weakness
Important Information
Daclatasvir Dihydrochloride Tablets should be used only as part of a healthcare professional's prescribed hepatitis C treatment regimen. It is generally combined with other direct-acting antiviral medicines because daclatasvir should not be used alone for HCV treatment. The choice and duration of therapy depend on factors such as HCV genotype, liver condition, previous treatment history, and other medicines being used. Inform your doctor about all prescription medicines, over-the-counter products, and supplements because significant drug interactions may occur. Do not stop or change treatment without medical advice.